Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Bully88on Apr 01, 2021 10:22am
213 Views
Post# 32922291

My Humble Opinion

My Humble OpinionSo

What to take of all of this.

I can definitely see the frustration here. They release a statement saying q4 results coming after market. then they dont come. Due to a "Technical dificulty" with Sedar. I definitely think this should have been handled differently.  as for how? maybe halt trading until q4 is released and make an official statement. not leaving everyone in the wind.

On top of that after multiple statements of Aristotle Released in Q1, we did not get that as well. what we were given was completely different scenario then what was expected.

Both can be deemed as misleading and bad practice from an investors point of view.

So as a lot of investors have been in for a long time and are up in the 100s of % I can definitely understand that trimming position or taking profits and walking away until things are officially up and running is a fair play.

I myself how ever like to focus on the positive side of this revelation.

Instead of Partnering up with someone potentially losing future value on their product by having to share profits, went out and BOUGHT THEIR OWN SET OF CLINICS.

Yes, we spent 15 million shares up front. yes that instantly dilutes share value by ALOT.

However, they also offered another 8 million shares based on results and hitting milestones.

so we paid roughly $36,000,000  based on yesterdays close price of 1.56

Starting this monday,

We will now have our own clinics that are already in the business of cancer.

This is why I ask how much money these clinics are making already.

It has to be in the millions a year already.

now add a dedicated lab with multiple tests including ARISTOTLE which we will be charging alone for $1500 dollars.  

From a Lab, to a Cancer Network with multiple streams of revenue.

The piece we are still in the dark with is COVID revenue.

SZLS predicted making 20-30 million in covid revenue. 

that right there covers this purchase straight up  and now we have like quadrupled in size and ability to make money in the cancer market. aka the biggest cause of death in the world. aka a global trillion dollar market.

Everyone here needs to grow a pair and stop worrying.

This is Basic business operations of a company that is going to grow. 

This new transaction should bring tears of joy to all of us, as now we are now in the Majorly profitable business of cancer.

Anyone buying at these levels are going to thank themselves in a couple years from now.

yes we just lost short term share price value, but in the grand scheme of things, this company is now fundamentally stronger then they were before this transaction.

Im going to sit back now and watch this thing climb for years to come.

Congrats to everyone who owns shares at these measily low prices.

Cheers,

Bully











<< Previous
Bullboard Posts
Next >>